| Literature DB >> 35165854 |
Sara H Alamri1,2, Ghalia N Abdeen3,4.
Abstract
Obesity in childbearing women leads to pregnancy-related complications such as gestational diabetes mellitus, pregnancy-associated hypertensive disorders, and macrosomia. Weight loss helps reduce these complications. Studies show bariatric surgery reduces obesity-related complications during and after pregnancy. However, bariatric surgery might be associated with adverse outcomes, such as low birth weight and small-for-gestational-age infants. In addition, several studies suggest pregnancy occurring less than a year post-bariatric surgery adversely affects pregnancy outcomes and causes micronutrients deficiency since the dramatic weight loss occurs in the first year. These adverse outcomes may lead to nutritional malabsorption, such as anemia and low vitamin B12 and folic acid levels. The review aims to overview obesity-related complications during pregnancy and the benefits and risks of bariatric surgery on pregnancy outcomes and maternal nutrition status.Entities:
Keywords: BMI; Maternal nutritional status; Neonatal outcomes; Obesity; Post-bariatric surgeries; Pregnancy complications; Pregnancy outcomes
Mesh:
Year: 2022 PMID: 35165854 PMCID: PMC8933294 DOI: 10.1007/s11695-021-05822-y
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129
Antepartum outcomes
| Study | PAHD | GDM | Preeclampsia | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity | |
| El-Gilany and Hammad (2010) [ | 0 | 4% | 4.9% | 6.1% | 0 | 3% | 4.4% | 8.6% | 0 | 3% | 3.8% | 5.9% |
| Fallatah et al. (2019) [ | NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO |
| 2.5% | 2.58% | 0.38% | 1.94% | 0.03% | 12.26% | 15.27% | 18.71% | 2.5% | 2.09% | 0.76% | 2.58% | |
| Sun et al. (2020) [ | UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity |
| 1.2% | 2.0% | 6.5% | 11.9% | 7.9% | 11.0% | 19.0% | 20.3% | - | - | - | - | |
In Fallatah et al.’s (2019) study, most of the pregnant participants were classified as obese class 1
GDM, gestational diabetes mellitus; PAHD, pregnancy-associated hypertensive disorders;
UWT, underweight; NW, normal weight, O/W, overweight; MO, morbid obesity
Fetomaternal outcomes
| NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fallatah et al. (2019) [ | 15% | 63.9% | 79% | 79.4% | 7.1% | 11.9% | 11.83% | 12.66% | - | 58.9% | 59.5% | 61.3% | ||||||||
| Schummers et al. (2015) [ | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | BMI ≥ 40 | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | BMI ≥ 40 | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | ≥ 40 | |||||
| 21.8% | 33.1% | 38.2% | 43.1% | 49.7% | 9.2% | 7.5% | 8.4% | 8.8% | 10.3% | - | - | - | - | - | ||||||
| Zhao et al. (2019) [ | 18.5 ≥ 22.9 | ≥ 24–24.9 | ≥ 25–27.9 | ≥ 28–29.9 | BMI ≥ 30 | 18.5 ≥ 22.9 | ≥ 24–24.9 | ≥ 25–27.9 | ≥ 28–29.9 | BMI ≥ 30 | 18.5 ≥ 22.9 | ≥ 24–24.9 | ≥ 25–27.9 | ≥ 28–29.9 | BMI ≥ 30 | |||||
| 21.5% | 28.6% | 28.3% | 33.5% | 32.8% | 5% | 5.4% | 7% | 8.7% | 15.3% | 2.8% | 2.7% | 2.7% | 2.2% | 2.3% | ||||||
In Zhao et al.’s (2019) study, there was no correlation between anemia and pregnant obese participants
UWT, underweight; NW, normal weight; O/W, overweight; MO, morbid obesity
Postpartum outcomes
| Study | Postpartum hemorrhage | Vaginal lacerations | Perianal lacerations | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO | NW | Obese I | Obese II | MO | |||||||
| Fallatah et al. (2019) [ | 1% | 1.3% | 0.8% | 1.3% | - | 7.4% | 3.4% | 3.2% | - | 4.7% | 1.5% | 2.6% | ||||||
| Haseeb (2017) [ | Non-obese | Obese | Non-obese | Obese | Non-obese | Obese | ||||||||||||
| 2% | 5.1% | - | - | - | - | |||||||||||||
| Rahman et al. (2020) [ | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||||||||||||
| UWT | NW | O/W | UWT | NW | O/W | UWT | NW | O/W | ||||||||||
| 1.11 (0.77–1.61) | 1 | 1.68 (1.12–2.53) | - | - | - | 1.00 (0.64–1.56) | 1 | 2.46 (1.54–3.92) | ||||||||||
UWT, underweight; NW, normal weight; O/W, overweight; MO, morbid obesity
Neonatal outcomes
| Study | Birth weight | Macrosomia | Stillbirth | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UWT | NW | O/W | Obese | UWT | NW | O/W | Obese | UWT | NW | O/W | Obese | ||||||||
| El-Gilany and Hammad (2010) [ | 26.90% | 11.70% | 9.60% | 5.80% | 0 | 0.70% | 2.10% | 4.40% | 1.50% | 0.70% | 1.10% | 1.10% | |||||||
| Schummers et al. (2015) [ | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | BMI ≥ 40 | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | BMI ≥ 40 | < 18.5 | 25– < 30 | 30– < 35 | 35– < 40 | BMI ≥ 40 | ||||
| 3187 ± 524 | 3505 ± 565 | 3548 ± 595 | 3572 ± 611 | 3619 ± 623 | 0.40% | 2.80% | 3.80% | 4.50% | 6.10% | 0.30% | 0.30% | 0.40% | 0.40% | 0.60% | |||||
| Fuchs et al. (2017) [ | UWT | NW | Obese | UWT | NW | O/W | Obese | UWT | NW | O/W | Obese | ||||||||
| Obese I | Obese II | MO | Class I | Class II | MO | Class I | Class II | MO | |||||||||||
| 3082 ± 662 | 3181 ± 687 | 3226 ± 741 | 3180 ± 828 | 3184 ± 804 | 3157 ± 842 | 4.30% | 6.60% | 9.20% | 10% | 9% | 9.10% | 0.30% | 0.50% | 0.70% | 0.80% | 0.90% | |||
UWT, underweight; NW, normal weight; O/W, overweight; MO, morbid obesity
Neonatal outcomes
| Study | SGA | LGA | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity | |||||||||||||
| Enomoto et al. (2016) [ | 13.21% | 8.67% | 7.24% | 7.06% | 5.46% | 10.05% | 17.36% | 22.60% | ||||||||||||
| Zhao et al. (2019) [ | < 18 kg/m2 | 18.5 ≥ 22.9 | ≥ 23–23.9 | ≥ 24–24.9 | ≥ 25–27.9 | ≥ 28–29.9 | BMI ≥ 30 | < 18 kg/m2 | 18.5 ≥ 22.9 | ≥ 23–23.9 | ≥ 24–24.9 | ≥ 25–27.9 | ≥ 28–29.9 | BMI ≥ 30 | ||||||
| 3.70% | 2.40% | 1.80% | 2.20% | 2.00% | 1.70% | 2.80% | 16.40% | 24.20% | 30% | 32.40% | 31.70% | 35.70% | 34.50% | |||||||
| Sun et al. (2020) [ | UWT | NW | O/W | Obesity | UWT | NW | O/W | Obesity | ||||||||||||
| 7.60% | %6.00 | 3.20% | 0 | 6.00% | 9.60% | 19.20% | 18.60% | |||||||||||||
UWT, underweight; NW, normal weight; O/W, overweight; MO, morbid obesity
Recommendations for total weight gain during pregnancy, by pregnancy BMI
| Pregnancy BMI | Total weight gain (kg) |
|---|---|
| Underweight (BMI < 18 kg/m2) | 12.5–18 |
| Normal weight (18.5–24.9 kg/m2) | 11.5–16 |
| Overweight (25.0–29.9 kg/m2) | 7–11.5 |
| Obese (BMI ≥ 30.0 kg/m2) | 5–9 |
The differentiation between complications in pregnant women with obesity and post-bariatric surgery pregnancy
| Stages of pregnancy | Complications associated with obese pregnant | Complications associated with post-bariatric surgery pregnant |
|---|---|---|
| 1st trimester | Vomiting [ Increase risk of miscarriage [ Anemia [ | Vitamin K deficiencies [ Vitamin D deficiency [ Vomiting [ Anemia [ |
| 2nd trimester | Gestational diabetes mellitus [ Pregnancy-associated hypertensive disorders [ | Vitamin B12 deficiency [ |
| 3rd trimester | Preeclampsia [ | Anemia [ Calcium deficiency [ Increases risk for osteoporosis [ |
| Postpartum | Postpartum hemorrhage [ Postnatal depression [ Vaginal lacerations [ Perianal lacerations [ | Thiamine deficiency [ Vitamin A deficiency [ |
Summary of the recommendations for post-bariatric surgery pregnancy
| Preconception | During pregnancy | Postpartum and breastfeeding | |
|---|---|---|---|
| Contraception | • Reproductive health counseling pre-bariatric surgery • To avoid oral contraceptives, due to decrease the drug bioavailability post-bariatric surgery • To use long-acting reversible contraception (etonogestrel implants and intrauterine devices) | ||
| Surgery-to-conception interval | • Postponing pregnancy from 12 to 18 months post-surgery • The dramatic weight loss occurs in the first year | ||
| Nutritional intake | • Monitor the weight prior to pregnancy • In case of underweight to refer patient to clinical dietitian to correct the weight • If the pregnant is obese, it is preferable to lose weight before pregnancy to avoid obesity-related complications in pregnancy | • Monitor nutrition intake during pregnancy and assess for GWG if it is inadequate or excessive • To avoid excessive or inadequate gestational weight gain; appropriate gestational weight gain 11.5–16 kg for normal BMI as the IOM guidelines stated • Protein intake should be at least 60 g per day • Oral supplementation might be considered in case of inadequate nutrient intake or in the presence of hyperemesis gravidarum | • Ensure adequate calorie and protein during breastfeeding • Avoid excessive calories to avoid weight retention after pregnancy |
| Maternal and fetal screening | • Guidelines for pregnant women post-bariatric surgery should be considered as they are high-risk pregnancies as diabetic and hypertensive pregnancies • Check fasting glucose level and hgb A1C if there is a history of diabetes • Check fetal growth every 4–6 weeks of pregnancy starting from the 24th week for LGA and SGA • Oral glucose tolerance test at 24–28 weeks as possible. Noted that it was associated with dumping syndrome in some cases of post-bariatric surgery pregnancy | ||
| Laboratory assessment | • Serum indices to be checked every 3 months: full blood count, vitamins A, B12, iron, ferritin, transferrin, and folic acid • Serum indices to be checked every 6 months: serum vitamin K1, vitamin D, protein, albumin, calcium, phosphate, magnesium, and PTH. In addition to renal and liver function Other extra serum indices to be checked especially during the 1st trimester: serum zinc, copper, selenium, and vitamin E | • Serum indices to be checked every 3 months: full blood count, vitamins A, B12, iron, ferritin, transferrin, and folic acid. In addition to transcobalamin • Serum indices to be checked every 6 months: INR, prothrombin time, serum vitamin K1, vitamin D, protein, albumin, calcium, phosphate, magnesium, and PTH. In addition to renal and liver function • Other extra serum indices to be checked especially during the 1st trimester: serum zinc, copper, selenium, and vitamin E | |
| Micronutrient’s supplementations | • Folic acid 0.4 mg should be taken daily since preconception and in the 1st trimester, 4–5 mg if obese or diabetic • Vitamin B12 taken as 1 mg IM for 3 months • Vitamin A taken as beta-carotene form. 5000 IU • If vitamin K deficiency noted to be taken orally in weekly doses • To keep vitamin D level above 50 nmol/L (1000 IU) • Add calcium as needed. 1200–1500 mg including dietary intake • Iron 45–60 mg (elemental iron) • Thiamine > 12 mg | • Thiamine supplementation 300 mg with vitamin B complex 3 times daily if pregnant women with vomiting. In case of prolonged vomiting, intravenous route should be considered • To continue with the suplmentation as periconception period • Additional supplements to be given in case of deficiencies | |